Predict your next investment

AireHealth company logo
Corporation
MOBILE & TELECOMMUNICATIONS | Mobile Software & Services / Healthcare
aire.health

See what CB Insights has to offer

Founded Year

2018

Stage

Unattributed | Alive

Total Raised

$6.57M

Last Raised

$6.42M | 1 yr ago

Revenue

$0000 

About AireHealth

AireHealth develops a connected nebulizer and medical app that provides patient engagement and medication adherence tracking for people living with respiratory illnesses.

AireHealth Headquarter Location

S Park Ave

Winter Park, Florida, 32789,

United States

Latest AireHealth News

Anaesthesia & Respiratory Devices Market Size Report Up to 2030 : Visiongain Research, Inc.

Jun 11, 2021

What are the main market drivers? Rising Geriatric Population: In recent years, the global geriatric population has experienced an unparalleled rise. Aging is associated with a steady reduction in lung function and a rise in respiratory disease prevalence, such as chronic obstructive pulmonary disease and asthma. With a rise in age, the respiratory system undergoes numerous anatomical, physiological, and immunological changes. The structural changes, involving deformities in the chest wall and thoracic spine, affect respiratory system functioning, and create difficulties in breathing. Soon, the incidence of respiratory diseases is projected to increase; thereby driving the global demand for anesthesia and respiratory devices. According to World Population Prospects data: the 2019 Revision, by 2050, one in six people worldwide will be over 65 years of age (16 percent), up from one in 11 in 2019 (9 percent). One in four individuals living in Europe and North America will be aged 65 or over by 2050. In 2018, individuals aged 65 or older outnumbered children under the age of five worldwide for the first time in history. It is estimated that the number of people aged 80 years or over will triple, from 143 million in 2019 to 426 million in 2050. Growing Respiratory Disease Burden: Respiratory diseases place an enormous global burden on health. Five of these diseases are among the world's most prominent causes of serious illness and death. An estimated 65 million people suffer from moderate to extreme chronic obstructive pulmonary disease (COPD), from which around 3 million die each year, making it the world's third leading cause of death – and the figures are-. About 334 million individuals suffer from asthma, which is the most common childhood chronic condition, affecting 14 percent of children worldwide. The prevalence of children's asthma is growing. Acute infections of the lower respiratory tract have been among the top three causes of death and impairment among both children and adults for decades. 10.4 million people developed tuberculosis (TB) in 2015, and 1.4 million died because of it. The world's most prevalent lethal neoplasm is lung cancer, which annually kills 1.6 million people; and the figures are rising. More than 10 percent of all disability-adjusted life-years (DALYs) account for respiratory disorders, a measure that measures the amount of active and productive life lost because of an illness. Respiratory diseases are second only (including stroke) to cardiovascular diseases. Five out of the 30 most common causes of death are respiratory diseases: COPD is third; inflammation of the lower respiratory tract is fourth; sixth is tracheal, bronchial and lung cancer; twelfth is TB, and twenty-eighth is asthma Where are the market opportunities? Significant Number of Investments & Partnerships to Offer Lucrative Revenue Avenues: The market attracts a significant number of investments and partnerships to meet the growing healthcare needs and speeds up the global marketing of advanced anesthesia and respiratory devices such as ventilators. For example, in July 2020, Advanced MedTech Holdings, a global leader in medical technology, and SEEDS Capital, Enterprise Singapore's investment arm, announced that they had invested US$ 10 million in Series A funding for ABM Respiratory Care (ABM), a company that develops new integrated airway clearance and ventilation solutions for medical devices . Boehringer Ingelheim completed the €105 million investment to expand related production activities at its Dortmund and Ingelheim sites in April 2019. For the next generation of this popular medical device, adequate capacity is now available. In Dortmund, additional production space for another flexible assembly line for the new Respimat was built. Of the overall investment, EUR 78 million went to this construction and production site, while the remaining EUR 27 million went to Ingelheim to buy new machinery, equipment, and supplies for an additional packaging line. These two programs operate together, which means that the entire phase of construction and production is carried out entirely in Germany, making Boehringer Ingelheim special in this regard. Increased Ventilator Production: The upsurge in respiratory illnesses due to the outbreak of the coronavirus has resulted in the increasing demand for ventilators around the world. Thus, the leading companies have ramped up their production capacity to meet the growing demand for ventilators for COVID-19 patients. Even the non-healthcare companies have come forward to produce ventilators amidst the COVID-19. Royal Philips issued an update in April 2020 on its plans to double its hospital ventilator volume by May 2020 and achieve a four-fold increase by the third quarter of 2020. This plan builds on the initial increase in production by Philips in the first three months of the year, which has already enabled hospitals in the most affected regions in China, southern Europe, and the US to provide additional ventilators that are vital for the care of COVID-19 patients. Philips launched the new Philips Respironics E30 ventilator, a compact, easy-to-use non-invasive and invasive ventilator equipped for large-scale manufacturing, to further meet the enormous global demand. What is the Competitive Landscape? Some of the companies profiled in the report include ResMed Inc., Medtronic plc, Vyaire Medical Inc., Masimo Corporation, Invacare Corporation, OMRON Healthcare, Inc., Smiths Medical, Royal Philips, and General Electric Company. For example, AireHealth Inc. entered into a merger agreement with a respiratory healthcare company, BreathResearch, which focuses on the detection of the rising decline in the status of respiratory health. This helps the company to include all BreathResearch’s assets – such as intellectual property, patents associated with respiratory devices, study of breathing sounds that utilize AI (artificial intelligence), and machine learning. Once the acquisition is completed this combined entity will operate as AireHealth. The VitalBreath virtual care platform will allow patients, caregivers, and clinicians to be further knowledgeable and joint in respiratory care, empowering quicker answers to aggravations and interpreting to fewer emergencies and fewer hospitalizations. This acquisition adds significant business opportunities to further boost AireHealth’s long-term strategy of becoming the industry's preferred partner for external innovation. Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with this invaluable  business intelligence . Find more research reports on the  Medical Devices Industry , please click on the following links:  About Visiongain Visiongain is one of the fastest growing and most innovative, independent, market intelligence around, the company publishes hundreds of  market research reports  which it adds to its extensive portfolio each year. These reports offer in-depth analysis across 18 industries worldwide. The reports cover a 10-year forecast, are hundreds of pages long, with in depth market analysis and valuable competitive intelligence data. Visiongain works across a range of vertical markets, which currently can influence one another, these markets include automotive, aviation, chemicals, cyber, defense, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors. Our customized and syndicated market research reports mean that you can have a bespoke piece of market intelligence customized to your very own business needs. Contact:

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Research containing AireHealth

Get data-driven expert analysis from the CB Insights Intelligence Unit.

CB Insights Intelligence Analysts have mentioned AireHealth in 2 CB Insights research briefs, most recently on May 6, 2021.

Expert Collections containing AireHealth

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

AireHealth is included in 7 Expert Collections, including Pharma Supply Chain.

P

Pharma Supply Chain

1,258 items

M

Medical Devices

10,978 items

Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.

C

Conference Exhibitors

5,302 items

D

Digital Health

12,254 items

Technologies, platforms, and systems that engage consumers for lifestyle, wellness, or health-related purposes; capture, store, or transmit health data; and/or support life science and clinical operations. (DiME, DTA, HealthXL, & NODE.Health)

T

Telehealth

2,732 items

Companies developing, offering, or using electronic and telecommunication technologies to facilitate the delivery of health & wellness services from a distance. *Columns updated as regularly as possible; priority given to companies with the most and/or most recent funding.

H

Health Monitoring & Diagnostics

838 items

Companies offering products that help assess patients’ state of health and well-being from a distance. Tagged as #RemoteMonitoring&Diagnostics

AireHealth Patents

AireHealth has filed 1 patent.

The 3 most popular patent topics include:

  • Abnormal respiration
  • Dosage forms
  • Drug delivery devices
patents chart

Application Date

Grant Date

Title

Related Topics

Status

4/28/2021

Respiratory physiology, Intensive care medicine, Dosage forms, Drug delivery devices, Abnormal respiration

Application

Application Date

4/28/2021

Grant Date

Title

Related Topics

Respiratory physiology, Intensive care medicine, Dosage forms, Drug delivery devices, Abnormal respiration

Status

Application

AireHealth Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

AireHealth Rank

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.